Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC3 | O15379 | 4/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.43 |
| ▸ | HDAC2 | Q92769 | 4/20 | 0.43 |
| ▸ | HDAC8 | Q9BY41 | 4/20 | 0.43 |
| ▸ | FFAR3 | O14843 | 3/20 | 0.43 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
| ▸ | CTSD | P07339 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 4/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | FNTA | P49354 | 1/20 | 0.34 |
| ▸ | FNTB | P49356 | 1/20 | 0.34 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.33 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1075702 | 1.00 | HDAC3 (0.43) | HDAC3HDAC1HDAC2HDAC8FFAR3 | |
| SCHEMBL444337 | 0.86 | CES1 (0.44) | CES2CES1TSHRALDH1A1THRB | |
| SCHEMBL4593133 | 0.86 | CES1 (0.44) | CES2CES1TSHRALDH1A1THRB | |
| Phenol SCHEMBL1415085 | 0.83 | HSD17B3 (0.42) | CES2CES1ALDH1A1TDP1LMNA | |
| Phenol SCHEMBL45542 | 0.83 | HSD17B3 (0.42) | CES2CES1ALDH1A1TDP1LMNA | |
| SCHEMBL27920516 | 0.82 | GPR84 (0.52) | CES2CES1TSHRALDH1A1THRB | |
| SCHEMBL11783133 | 0.79 | HDAC3 (0.48) | HDAC3HDAC1HDAC2HDAC8FFAR3 | |
| SCHEMBL16664 | 0.79 | HDAC3 (0.48) | HDAC3HDAC1HDAC2HDAC8FFAR3 | |
| SCHEMBL671878 | 0.79 | — | — | |
| SCHEMBL2350817 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3807 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4329667-B1 | IMPLANTABLE DEVICE AND THERAPEUTIC SYSTEM WITH PASSIVE OXYGENATION | SANOFI SA (FR) | 2026-05-06 | — | — | EP | claimed |
| EP-3191534-B1 | AMPHIPHILIC BLOCK COPOLYMERS FOR DELIVERY OF ACTIVE AGENTS | RWTH AACHEN (DE) | 2025-10-01 | — | — | EP | claimed |
| EP-4329670-B1 | MANUFACTURING A THERAPEUTIC DEVICE CONTAINING A PLURALITY OF CELLS | SANOFI SA (FR) | 2025-04-30 | — | — | EP | claimed |
| EP-3831858-B1 | VINYL CHLORIDE-BASED COPOLYMER AND METHOD FOR PREPARING SAME | HANWHA SOLUTIONS CORP (KR) | 2024-12-04 | — | — | EP | claimed |
| US-20240156808-A1 | Compositions and methods to improve the therapeutic benefit of suboptimally chemical compounds and biological therapies including substituted camptothecins such as irinotecan and topotecan for the treatment of benign and neoplastic hyperproliferative disease conditions, infections, inflammatory and immunological diseases | EDISON ONCOLOGY (US) | 2024-05-16 | — | — | US | claimed |
| EP-3817764-B1 | BIOPHARMACEUTICAL AGENTS FOR USE IN REDUCING LIPID CONTENT IN CELLS | UNIV JOHANNESBURG WITWATERSRAND (ZA) | 2024-04-17 | — | — | EP | claimed |
| EP-4333807-A1 | NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD) COMPOSITIONS, METHODS OF MANUFACTURING THEREOF, AND METHODS OF USE THEREOF | Sovida Solutions Ltd. (GB) | 2024-03-13 | — | — | EP | claimed |
| EP-3453390-B1 | POLYMERIZED DRUG-CONTAINING PHARMACEUTICAL COMPOSITION | BIODYNAMIC RES FOUNDATION (JP) | 2024-02-14 | — | — | EP | claimed |
| CN-117529306-A | Nicotinamide Adenine Dinucleotide (NAD) compositions, methods of making and methods of using the same | 索维达解决方案有限公司 | 2024-02-06 | — | — | CN | claimed |
| EP-4308163-A1 | PEGYLATED T CELL ENGAGER WITH DUAL SPECIFICITIES TO CD3 AND CD19 | Shenzhen Enduring Biotech, Ltd. (CN) | 2024-01-24 | — | — | EP | claimed |
| EP-0688207-A1 | LIPID-POLYMER CONJUGATES AND LIPOSOMES | SEQUUS PHARMACEUTICALS, INC. (US) | 1995-12-27 | — | — | EP | claimed |
| EP-0683676-A1 | DIRECTED BIODISTRIBUTION OF SMALL MOLECULES | NEORX CORPORATION (US) | 1995-11-29 | — | — | EP | claimed |
| WO-1994029479-A9 | OLIGONUCLEOTIDES WHICH INHIBIT HIV PROTEASE FUNCTION | — | 1995-02-02 | — | — | WO | claimed |
| WO-1994029479-A1 | OLIGONUCLEOTIDES WHICH INHIBIT HIV PROTEASE FUNCTION | PHARMAGENICS, INC. (US) | 1994-12-22 | — | — | WO | claimed |
| WO-1994020073-A1 | LIPID-POLYMER CONJUGATES AND LIPOSOMES | LIPOSOME TECHNOLOGY, INC. (US) | 1994-09-15 | — | — | WO | claimed |
| WO-1994017829-A1 | DIRECTED BIODISTRIBUTION OF SMALL MOLECULES | NEORX CORPORATION (US) | 1994-08-18 | — | — | WO | claimed |
| EP-0591233-A1 | POLYMER COATINGS | BIOINTERACTIONS LIMITED (GB) | 1994-04-13 | — | — | EP | claimed |
| WO-1994001448-A1 | OLIGONUCLEOTIDES MODIFIED WITH CONJUGATE GROUPS | PHARMAGENICS, INC. (US) | 1994-01-20 | — | — | WO | claimed |
| WO-1993023570-A1 | OLIGONUCLEOTIDES HAVING CONJUGATES ATTACHED AT THE 2'-POSITION OF THE SUGAR MOIETY | PHARMAGENICS, INC. (US) | 1993-11-25 | — | — | WO | claimed |
| WO-1993000391-A1 | POLYMER COATINGS | BIOINTERACTIONS LIMITED (GB) | 1993-01-07 | — | — | WO | claimed |